MEGA_MEGA LIFESCIENCES (MEGA.BK) Financials
MEGA.BK Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 14.4 billion | 4.4 billion |
| 2023-12-31 | 14.5 billion | 5.2 billion |
| 2023-09-30 | 14.7 billion | 5.8 billion |
| 2023-06-30 | 14.7 billion | 5.6 billion |
MEGA.BK Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | 511.8 million | ? |
| 2023-12-31 | 314.2 million | -115.0 million |
| 2023-09-30 | 608.3 million | -123.2 million |
| 2023-06-30 | 506.4 million | -88.2 million |
MEGA.BK Net Income
| Date | Net Income |
|---|---|
| 2024-03-31 | 477.6 million |
| 2023-12-31 | 473.2 million |
| 2023-09-30 | 535.5 million |
| 2023-06-30 | 530.9 million |
MEGA.BK Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | - | - | 240.2 million |
| 2023-12-31 | 2.7 billion | - | 175.8 million |
| 2023-09-30 | 2.5 billion | - | 160.5 million |
| 2023-06-30 | 2.8 billion | - | 172.8 million |
MEGA.BK Shares Outstanding
MEGA.BK Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 37.9 million | - | 1.1 billion | - |
| 2023-12-31 | 77.1 million | - | 1.2 billion | 260.3 million |
| 2023-09-30 | 88.4 million | - | 407.0 million | 613.8 million |
| 2023-06-30 | 46.9 million | - | 421.2 million | 617.1 million |
MEGA.BK Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 3.7 billion | 2.0 billion |
| 2023-12-31 | 4.2 billion | 2.3 billion |
| 2023-09-30 | 3.8 billion | 2.1 billion |
| 2023-06-30 | 4.0 billion | 2.2 billion |
MEGA.BK
Price: THB40.25
Dividend Yield: 3.95%
Forward Dividend Yield: 1.24%
Payout Ratio: 10.92%
Dividend Per Share: 0.50 THB
Earnings Per Share: 2.29 THB
P/E Ratio: 18.23
Exchange: SET
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 35.1 billion
Average Dividend Frequency: 2
Years Paying Dividends: 11
DGR3: 23.77%
DGR5: 0.62%